BeiGene, Ltd. (BGNE) Social Stream
BEIGENE LTD (BGNE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BEIGENE LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 5 | $431 | $343.3 | $403.716 | $171.1 | 135.95% |
| 2022-01-06 | 6 | $431 | $283.3 | $392.46 | $171.1 | 129.37% |
| 2022-01-12 | 6 | $431 | $283.3 | $388.716 | $171.1 | 127.19% |
| 2022-01-18 | 6 | $431 | $283.3 | $380.883 | $171.1 | 122.61% |
| 2022-01-28 | 6 | $431 | $283.3 | $367.55 | $171.1 | 114.82% |
| 2022-02-08 | 6 | $431 | $283.3 | $354.216 | $171.1 | 107.02% |
| 2022-02-25 | 6 | $431 | $283.3 | $348.55 | $171.1 | 103.71% |
| 2022-02-28 | 6 | $431 | $254 | $332.333 | $171.1 | 94.23% |
| 2022-03-17 | 6 | $431 | $177 | $300.2 | $171.1 | 75.45% |
| 2022-04-28 | 6 | $431 | $177 | $313.166 | $171.1 | 83.03% |
| 2022-05-06 | 6 | $431 | $177 | $296.166 | $171.1 | 73.1% |
| 2022-05-18 | 6 | $431 | $177 | $289.833 | $171.1 | 69.39% |
| 2022-07-27 | 6 | $431 | $177 | $288.666 | $171.1 | 68.71% |
| 2022-08-05 | 6 | $431 | $177 | $284.316 | $171.1 | 66.17% |
| 2022-08-09 | 6 | $431 | $177 | $271.983 | $171.1 | 58.96% |
| 2022-08-13 | 6 | $431 | $177 | $270.6 | $171.1 | 58.15% |
The Trend in the Analyst Price Target
Over the past 40 weeks, BGNE's average price target has gone down $133.12.
BGNE reports an average of 55.97% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 7 | 431 | 343.3 | 403.716 | 349.84 | 15.4% |
| 2021-11-08 | 6 | 431 | 343.3 | 404.460 | 349.84 | 15.61% |
| 2022-02-08 | 6 | 431 | 283.3 | 354.216 | 211.19 | 67.72% |
| 2022-08-05 | 6 | 431 | 177.0 | 284.316 | 194.47 | 46.2% |
| 2022-08-13 | 6 | 431 | 177.0 | 270.600 | 193.97 | 39.51% |
BGNE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.75 | 3 | 1 | 2 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 122 days, BGNE's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BGNE as an investment opportunity.
- In terms of how BEIGENE LTD fares relative to all US stocks, note that its average analyst price target is higher than 1911.16% of that group.
- In the context of stocks in the large market cap category, BEIGENE LTD's number of analysts covering the stock is greater than 197.38% of them.
- In terms of how BEIGENE LTD fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 1625.46% of that group.
- In the context of stocks in the large market cap category, BEIGENE LTD's variance in analysts' estimates is lower than -1081.81% of them.
In the Pharmaceutical Products industry, ALNY, ALKS, and ABCL are the three stocks most similar to BEIGENE LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BGNE a Buy, Hold or Sell? See the POWR Ratings now!